Vlad Vitoc, MD, MBA
Chief Executive Officer and Chairman
Sergei M. Gryaznov, PhD
Chief Scientific Officer
Jeffrey C. Himmelreich
Head of Finance
Vlad Vitoc, MD, MBA
Chief Executive Officer and Chairman
Dr. Vitoc is our Chairman of Board, Chief Executive Officer, and President. Dr. Vitoc has a broad array of experience across commercial strategic analysis and planning and medical affairs, in which he has 20 years of experience. During that time, Dr. Vitoc has managed and supported over 20 early, launch, and mature stage compounds, which have included targeted therapies and immune therapies across more than 25 tumor types, including colorectal cancer, hepatocellular carcinoma, lung cancer, breast cancer, prostate cancer, and renal cell carcinoma. Vlad received an M.D. from the University of Medicine and Pharmacy “Iuliu Hatieganu”, Cluj-Napoca, Romania, and his M.B.A. from the University of South Carolina.
Sergei M. Gryaznov, PhD
Chief Scientific Officer
Dr. Gryaznov is our Chief Scientific Officer. Dr. Gryaznov is an internationally recognized scientist and expert in the areas of modern drug discovery and development, oncology, telomerase, immune-regulatory therapeutics, nucleosides, nucleotides, DNA and RNA analogues, lipid and other conjugates, small molecules, and nucleic acid based therapeutic agents. Dr. Gryaznov is the co-inventor of a novel telomere-by-telomerase-targeting therapeutic approach to potential cancer treatment and responsible for leading the research team that characterized THIO’s telomere targeting activity, our lead compound in development. Dr. Gryaznov obtained an M.S., with Honors, in Organic Chemistry and a Ph.D. in Chemistry of Natural Products from M.V. Lomonosov Moscow State University. Dr. Gryaznov also completed a post-doctoral fellowship program in Chemistry at Northwestern University in Evanston, IL.
Jeffrey C. Himmelreich
Head of Finance
Mr. Himmelreich is our Head of Finance and brings in over 20 years of experience to MAIA. Most recently, served as Chief Financial Officer for a privately held manufacturer. Prior roles include various senior accounting positions in public traded companies in the healthcare and manufacturing sectors. In these roles, his responsibilities included financial reporting, merger and acquisitions, legal and audit liaison, joint ventures, and internal audit. Mr. Himmelreich received a Bachelor of Science in Accounting from Indiana University of Pennsylvania and received an MBA from Pennsylvania State University. Mr. Himmelreich holds an active CPA licensed in the state of Pennsylvania and is a Chartered Global Management Accountant.
